Sign in

DAVI

DAVION HEALTHCARE PLC

DAVION HEALTHCARE PLC is a surgical and medical instruments and apparatus company based in Clonakilty.1

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with another stock.

  • TickerDAVI1
  • IndustrySurgical & Medical Instruments & Apparatus1
  • HeadquartersG41
  • Incorporated inCyprus2
  • Business addressUnit A, West Cork Business & Technology Park, Clonakilty, P85 Fv482
  • Filer categoryNon-accelerated filer, Emerging growth company2
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

(where applicable), manufactured, sold and internationally distributed through licensing agreements.3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Every line of the income statement as filed: the last 2 fiscal years, latest first.4

Period ending2025-12-312024-12-31
Administrative expenses-824.0K EUR-1.3M EUR
Research and development expenses0 EUR-8.2K EUR
Operating loss-824.0K EUR-1.3M EUR
Income tax expense0 EUR0 EUR
Loss and total comprehensive loss for the year-824.0K EUR-1.3M EUR
Basic-0.03 EUR-0.06 EUR
Diluted-0.03 EUR-0.06 EUR
Basic25.0M shares22.9M shares
Diluted25.0M shares22.9M shares

Compare DAVION HEALTHCARE PLC with another company

Corporate structure

DAVION HEALTHCARE PLC sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of DAVION HEALTHCARE PLC

  • Jack Harry Kaye Filed SCHEDULE 13D/A on DAVION HEALTHCARE PLC, latest Aug 11, 2026 (2 filings since Apr 17, 2026)
  • DAVION HEALTHCARE PLC G4

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

Leadership

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive Officer, DirectorJack Harry Kaye named Sep 8, 20265

Calendar

Coming up

  1. Oct 22, 2026IPO Expected; NASDAQ Global.6

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

26 filings to the SEC since October 2021: 2 annual reports, 1 insider forms, 2 large holders, 1 private raises, 20 other. The latest 20:

  1. Oct 13, 2026424B3 EDGAR
  2. Sep 15, 20266-K EDGAR
  3. Sep 8, 2026D EDGAR
  4. Sep 2, 2026POS AM EDGAR
  5. Aug 17, 2026POS AM POST EFFECTIVE AMENDMENT NO. 6 EDGAR
  6. Aug 11, 2026SCHEDULE 13D/A EDGAR
  7. May 6, 202620-F/A FORM 20-F FOR DEC 2025 AMENDMENT 1 EDGAR
  8. May 1, 2026POS AM POST-EFFECTIVE AMENDMENT #5 EDGAR
  9. Apr 30, 202620-F FORM 20-F FOR DEC 2025 EDGAR
  10. Apr 17, 2026SCHEDULE 13D EDGAR
  11. Apr 17, 20263 EDGAR
  12. Apr 6, 2026POS AM AMENDMENT NO. 4 EDGAR
  13. Mar 4, 2026POS AM POST EFFECTIVE AMENDMENT NO. 3 EDGAR
  14. Feb 4, 2026POS AM POS AM NO. 2 EDGAR
  15. Jan 5, 20266-K EDGAR
  16. Dec 9, 2025POS AM AMENDMENT NO 1 EDGAR
  17. Dec 8, 2025AW EDGAR
  18. Dec 5, 2025F-1/A AMENDMENT NO. 3 TO FORM F-1 EDGAR
  19. Dec 2, 20256-K EDGAR
  20. Nov 28, 20258-A12B EDGAR

The 26 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

  • Jack Harry KayeSCHEDULE 13D/A, 2 filings Apr 17, 2026 to Aug 11, 20267

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$350.0K 2026–2026
Money received by yearMoney received by year, 2026–2026: $350.0K in all. Private raises (Form D) $350.0K.$0$100K$200K$300K$400K2026 · Private raises (Form D): $350.0K2026
Figures by year
YearPrivate raises (Form D)Total
2026$350.0K$350.0K

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

  1. Aug 26, 2026Raised $350,000 in a private offering of debt5 Form D: $10 million offered in all Form D

SEC filer profile

How DAVION HEALTHCARE PLC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARDAVION HEALTHCARE PLC1
  • CIK0002039072
  • Filer statusNon-accelerated filer an emerging growth company; a shell company3
  • Incorporated inL23
  • Fiscal year endsDecember 311
  • Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business addressUnit A, West Cork Business & Technology Park, Clonakilty, County Cork P85 FV48, Ireland1
  • Phone357 250400521
  • Shares outstanding25,000,000 shares as of Dec 31, 20253
  • AuditorWithum, Smith + Brown, PC, Philadelphia, Pennsylvania PCAOB ID 100; no auditor attestation of internal control over financial reporting3
  • On EDGAR sinceAug 4, 20251
  • Filings26 in all: POS AM (7), 6-K (3), F-1/A (3), CORRESP (2), 20-F (1), 20-F/A (1), 3 (1), 424B3 (1)1
    All 15 form types

    8-A12B (1), AW (1), D (1), F-1 (1), SCHEDULE 13D (1), SCHEDULE 13D/A (1), UPLOAD (1)

  • Latest filingsAnnual report (20-F) Apr 30, 2026

Securities registered for trading

ClassSymbolExchange
Common SharesDAVINASDAQ

From the cover page of the 20-F filed Apr 30, 2026 (Section 12(b) of the Exchange Act).3

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7